NCT05737342

Effect of ANKASCIN 568-P Products on Decreasing HbA1c and Regulating Blood Glucose

Effect of ANKASCIN 568-P Products on Decreasing HbA1c and Regulating Blood Glucose- A Double-blind, Placebo-controlled Clinical Research

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 80 (estimated)
• Sponsor: SunWay Biotech Co., LTD. · Industry
• Sex: All
• Age: 20 Years
• Healthy volunteers: Not accepted

Summary

This study is a randomized, double-blind, placebo-controlled, parallel-controlled trial (24 weeks in total), divided into three periods (screening, treatment, and discontinuation follow-up)

Detailed description

This trial is a randomized double-blind human trial, mainly to investigate the effect of long-term consumption of red yeast rice products on reducing glycated hemoglobin (HbA1c) and regulating blood sugar. It is expected to recruit 80 subjects for a period of 24 weeks. The test group takes 2 capsules of red yeast rice per day (Each capsule contains 440mg ANKASCIN 568-P), the control group took placebo capsules daily, blood samples were collected for biochemical analysis at 0, 4, 12, and 24 weeks, and the general body position measurement, blood pressure, Blood lipids, blood sugar and other related changes, and monitor liver, kidney, thyroid function.

Conditions

• High Blood Sugar
• Metabolic Syndrome

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	ANKASCIN 568-P Red yeast rice capsules	Product ingredients: ANKASCIN 568-P red yeast rice product 440 mg,microcrystalline ,cellulose,Maltodextrin; capsule shell composition: HPMC (hydroxypropyl methylcellulose), purified water, titanium dioxide, gellan gum.
DIETARY_SUPPLEMENT	Placebo Capsules	Maltodextrin was used as a placebo

Timeline

• Start date: 2023-04-01
• Primary completion: 2025-10-31
• Completion: 2025-10-31
• First posted: 2023-02-21
• Last updated: 2025-08-28

Locations

1 site across 1 country: Taiwan